These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 33567572)

  • 1. Beneficial Actions of
    Hur S; Jang E; Lee JH
    Nutrients; 2021 Feb; 13(2):. PubMed ID: 33567572
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cultivated Orostachys japonicus extract inhibits VEGF-induced angiogenesis via regulation of VEGFR2 signaling pathway in vitro and in vivo.
    Cho HD; Lee KW; Won YS; Kim JH; Seo KI
    J Ethnopharmacol; 2020 Jun; 256():112664. PubMed ID: 32045685
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-cancer effects of the aqueous extract of Orostachys japonica A. Berger on 5-fluorouracil-resistant colorectal cancer via MAPK signalling pathways in vitro and in vivo.
    Kim JW; Kim SH; Mariappan R; Moon D; Kim J; Yoon SP
    J Ethnopharmacol; 2021 Nov; 280():114412. PubMed ID: 34265383
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies on the Anti-Angiogenic Activities of Wild and Cultivated Orostachys japonicus Extracts in Human Umbilical Vein Endothelial Cells.
    Cho HD; Lee KW; Won YS; Shin DY; Seo KI
    J Food Sci; 2019 Jul; 84(7):1764-1775. PubMed ID: 31218702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kaempferol inhibits angiogenic ability by targeting VEGF receptor-2 and downregulating the PI3K/AKT, MEK and ERK pathways in VEGF-stimulated human umbilical vein endothelial cells.
    Chin HK; Horng CT; Liu YS; Lu CC; Su CY; Chen PS; Chiu HY; Tsai FJ; Shieh PC; Yang JS
    Oncol Rep; 2018 May; 39(5):2351-2357. PubMed ID: 29565448
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calpain inhibitory flavonoids isolated from Orostachys japonicus.
    Je Ma C; Jung WJ; Lee KY; Kim YC; Sung SH
    J Enzyme Inhib Med Chem; 2009 Jun; 24(3):676-9. PubMed ID: 18825531
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential Therapeutic Targets of Quercetin, a Plant Flavonol, and Its Role in the Therapy of Various Types of Cancer through the Modulation of Various Cell Signaling Pathways.
    Almatroodi SA; Alsahli MA; Almatroudi A; Verma AK; Aloliqi A; Allemailem KS; Khan AA; Rahmani AH
    Molecules; 2021 Mar; 26(5):. PubMed ID: 33804548
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sempervivum davisii: phytochemical composition, antioxidant and lipase-inhibitory activities.
    Uzun Y; Dalar A; Konczak I
    Pharm Biol; 2017 Dec; 55(1):532-540. PubMed ID: 27937045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aqueous extract of Orostachys japonicus A. Berger exerts immunostimulatory activity in RAW 264.7 macrophages.
    Park HJ; Yang HJ; Kim KH; Kim SH
    J Ethnopharmacol; 2015 Jul; 170():210-7. PubMed ID: 25978952
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dioscin inhibits colon tumor growth and tumor angiogenesis through regulating VEGFR2 and AKT/MAPK signaling pathways.
    Tong Q; Qing Y; Wu Y; Hu X; Jiang L; Wu X
    Toxicol Appl Pharmacol; 2014 Dec; 281(2):166-73. PubMed ID: 25111127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kaempferol and quercetin, components of Ginkgo biloba extract (EGb 761), induce caspase-3-dependent apoptosis in oral cavity cancer cells.
    Kang JW; Kim JH; Song K; Kim SH; Yoon JH; Kim KS
    Phytother Res; 2010 Jan; 24 Suppl 1():S77-82. PubMed ID: 19585476
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dual blockade of VEGFR1 and VEGFR2 by a novel peptide abrogates VEGF-driven angiogenesis, tumor growth, and metastasis through PI3K/AKT and MAPK/ERK1/2 pathway.
    Sadremomtaz A; Mansouri K; Alemzadeh G; Safa M; Rastaghi AE; Asghari SM
    Biochim Biophys Acta Gen Subj; 2018 Dec; 1862(12):2688-2700. PubMed ID: 30251659
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antitumor effect of Quercetin on Y79 retinoblastoma cells via activation of JNK and p38 MAPK pathways.
    Liu H; Zhou M
    BMC Complement Altern Med; 2017 Dec; 17(1):531. PubMed ID: 29237430
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The epigallocatechin gallate derivative Y
    Liao ZH; Zhu HQ; Chen YY; Chen RL; Fu LX; Li L; Zhou H; Zhou JL; Liang G
    J Ethnopharmacol; 2020 Sep; 259():112852. PubMed ID: 32278759
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bioconverted Orostachys japonicas Extracts Suppress Angiogenic Activity of Ms-1 Endothelial Cells.
    Lee SG; Kim JS; Lee HS; Lim YM; So JH; Hahn D; Ha YS; Nam JO
    Int J Mol Sci; 2017 Dec; 18(12):. PubMed ID: 29206202
    [No Abstract]   [Full Text] [Related]  

  • 16. Isogambogenic acid inhibits tumour angiogenesis by suppressing Rho GTPases and vascular endothelial growth factor receptor 2 signalling pathway.
    Fan Y; Peng A; He S; Shao X; Nie C; Chen L
    J Chemother; 2013 Oct; 25(5):298-308. PubMed ID: 24070138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Herbal compound farnesiferol C exerts antiangiogenic and antitumor activity and targets multiple aspects of VEGFR1 (Flt1) or VEGFR2 (Flk1) signaling cascades.
    Lee JH; Choi S; Lee Y; Lee HJ; Kim KH; Ahn KS; Bae H; Lee HJ; Lee EO; Ahn KS; Ryu SY; Lü J; Kim SH
    Mol Cancer Ther; 2010 Feb; 9(2):389-99. PubMed ID: 20103598
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of Endothelial SCUBE2 (Signal Peptide-CUB-EGF Domain-Containing Protein 2), a Novel VEGFR2 (Vascular Endothelial Growth Factor Receptor 2) Coreceptor, Suppresses Tumor Angiogenesis.
    Lin YC; Liu CY; Kannagi R; Yang RB
    Arterioscler Thromb Vasc Biol; 2018 May; 38(5):1202-1215. PubMed ID: 29545238
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-tumor actions of major component 3'-O-acetylhamaudol of Angelica japonica roots through dual actions, anti-angiogenesis and intestinal intraepithelial lymphocyte activation.
    Kimura Y; Sumiyoshi M; Baba K
    Cancer Lett; 2008 Jun; 265(1):84-97. PubMed ID: 18358599
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CEP-7055: a novel, orally active pan inhibitor of vascular endothelial growth factor receptor tyrosine kinases with potent antiangiogenic activity and antitumor efficacy in preclinical models.
    Ruggeri B; Singh J; Gingrich D; Angeles T; Albom M; Yang S; Chang H; Robinson C; Hunter K; Dobrzanski P; Jones-Bolin S; Pritchard S; Aimone L; Klein-Szanto A; Herbert JM; Bono F; Schaeffer P; Casellas P; Bourie B; Pili R; Isaacs J; Ator M; Hudkins R; Vaught J; Mallamo J; Dionne C
    Cancer Res; 2003 Sep; 63(18):5978-91. PubMed ID: 14522925
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.